Karen Knudsen: Honored to share that I’ve taken the helm of Parker Institute for Cancer Immunotherapy as CEO

About the role

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy.

Responsibilities

• Lead the organization in accelerating the timeline from bold discovery to patient impact.
• Fund high-risk, high-reward science and ensure promising ideas don’t stall.
• Advance clinical testing and company creation to get therapies to market faster.
• Work on mRNA cancer vaccines and next-gen immunotherapy strategies targeting difficult-to-treat cancers.

Qualifications

• Spent career at the intersection of science, healthcare, strategy, and mission.
• Led major academic cancer centers and transformed national organizations.
• Worked alongside partners across biotech and policy.

Benefits

• Unite top scientists, clinicians, and institutions in a national model.
• Supports the development of innovative cancer treatments.
• Accelerates the translation of scientific discoveries into patient care.

Pay

N/A

Schedule

N/A

Skills

• Leadership in academic cancer centers.
• Strategic vision and execution.
• Collaboration with partners across biotech and policy.
• Expertise in cancer research and treatment.

Benefits

• Opportunities for innovation and impact in cancer research.
• Access to a network of top scientists and clinicians.
• Chances to contribute to groundbreaking cancer treatments.

Pay

N/A

Schedule

N/A